• Return to Headlines

22.5% Return Seen to Date on SmarTrend Ligand Pharm Call (LGND)

By James Quinn

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on November 13th, 2018 at $152.60. In approximately 4 months, Ligand Pharm has returned 22.53% as of today's recent price of $118.21.

In the past 52 weeks, Ligand Pharm share prices have been bracketed by a low of $98.56 and a high of $278.62 and are now at $118.21, 20% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 1.2%.

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders and certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Ligand Pharm.

Log in and add Ligand Pharm (LGND) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ligand pharm

Ticker(s): LGND